ZOLL Respicardia Email Format

Medical Equipment ManufacturingMinnesota, United States51-200 Employees

ZOLL Respicardia develops medical devices focused on Central Sleep Apnea, a condition in which the brain fails to signal breathing during sleep. Its remedy, the remedē System, is an implantable stimulator designed to normalize breathing patterns for people with CSA. Based in Eden Prairie, Minnesota, it operates as a mid-sized medical equipment manufacturer focused on sleep-disordered breathing technologies.
The company serves individuals diagnosed with CSA and clinicians who treat the condition, addressing the disruption to breathing during sleep that can affect health and quality of life. Since its 2021 acquisition by ZOLL, the broader organization has continued to advance medical device offerings, including a 2025 launch of a fifth-generation LifeVest wearable cardioverter defibrillator, highlighting ongoing activity in the medical devices sector.

Get verified ZOLL Respicardia emails free

Company overview Employee directory